{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/urticaria/diagnosis/diagnosis/","result":{"pageContext":{"chapter":{"id":"513fb45b-36c0-59b5-8f88-13b10509caee","slug":"diagnosis","fullItemName":"Diagnosis","depth":2,"htmlHeader":"<!-- begin field 5020cb53-0db0-4db3-b9d9-b8eebbf8b455 --><h2>How should I diagnose urticaria?</h2><!-- end field 5020cb53-0db0-4db3-b9d9-b8eebbf8b455 -->","summary":"","htmlStringContent":"<!-- begin item 6ccb499b-5e7e-4827-aba2-be2ebeac4ddc --><!-- begin field fe5bb8d9-6435-42ba-be95-3fae32628911 --><ul><li><strong>Take a history. </strong>Ask about (and fully document):<ul><li>Time of onset of the disease.</li><li>The frequency, duration, and pattern of recurrence of the weals.<ul><li>In acute urticaria, symptoms last for less than 6 weeks.</li><li>In chronic urticaria, symptoms persist for 6 weeks or longer (on a nearly daily basis). </li><li>In some people urticaria is episodic, lasting for hours or days and recurring over months or years.</li></ul></li><li>The shape, size, distribution, and nature of the weals, including whether they are itchy or painful.</li><li>Severity of symptoms. Consider assessing the severity of urticaria using a validated tool, such as the <a href=\"http://www.itchingforanswers.ca/docs/UAS7-Questionnaire.pdf\" data-hyperlink-id=\"ed1c9f07-3f2e-4ef1-92fb-a98d0055fc7c\">Urticaria Activity Score</a> (UAS7).<ul><li>Using the UAS7, the person records the severity of itching and the number of weals daily for 7 days.</li><li>A score of less than 7 in 1 week indicates control of disease, whereas a score of  more than 28 per week indicates severe disease.</li></ul></li><li>Any known <a class=\"topic-reference internal-reference\" href=\"/topics/urticaria/background-information/causes-trigger-factors/\">causes/trigger factors</a>, such as stress, drug treatments (including complementary and topical treatments), insect bites and stings, exercise, and certain foods.<ul><li>A detailed history usually enables an immunoglobulin E (IgE)-mediated food allergy to be excluded as a cause of urticaria.</li><li>In IgE-mediated food allergy, symptoms typically occur reproducibly within 1 hour of exposure to the offending food rather than coming on overnight or being present first thing in the morning.</li></ul></li><li>Any treatment(s) tried and response to the treatment(s).</li><li>A family history of urticaria or atopy.</li><li>Any co-existing medical conditions, such as previous or current allergies, infections, psychosomatic or psychiatric diseases, or autoimmune conditions.</li><li>Any gastrointestinal symptoms.</li><li>Occurrence of symptoms in relation to the menstrual cycle (in women), foreign travels, work, or hobbies.</li></ul></li><li><strong>Examine the person.</strong> <ul><li>Weals can vary in size (from a few millimetres to hand-sized lesions), may be single or numerous, and can be localized or generalized.</li><li>They consist of three typical features:<ul><li>A central swelling of variable size (red or white in colour), almost invariably surrounded by an area of redness (flare).</li><li>Associated itching or, sometimes, burning sensation.</li><li>A fleeting nature, with the skin returning to its normal appearance, usually within 1–24 hours.</li></ul></li></ul></li><li><strong>Consider </strong><a class=\"topic-reference internal-reference\" href=\"/topics/urticaria/diagnosis/differential-diagnosis/\">alternative&nbsp;diagnoses</a><strong>.</strong><ul><li>In particular, consider <a class=\"topic-reference internal-reference\" href=\"/topics/urticaria/diagnosis/differential-diagnosis/\">vasculitic urticaria</a> if the lesions remain for longer than 24 hours and are painful, non-blanching, and palpable (leaving a residual pigmented lesion, such as petechial haemorrhage, purpura, or bruising), especially if the person also has systemic symptoms, such as fever, malaise, and arthralgia.</li></ul></li><li><strong>Investigations are not usually required. </strong>However, when a cause cannot be identified from the history, and <a class=\"topic-reference internal-reference\" href=\"/topics/urticaria/diagnosis/differential-diagnosis/\">differential diagnoses</a> have been excluded, consider appropriate investigations to help identify the cause (especially in people with chronic urticaria). See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/urticaria/diagnosis/investigations/\">investigations</a> for more information.</li><li><strong>If angioedema or anaphylaxis is suspected, </strong>see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/angio-oedema-anaphylaxis/\">Angio-oedema and anaphylaxis</a> for management information.</li></ul><!-- end field fe5bb8d9-6435-42ba-be95-3fae32628911 --><!-- end item 6ccb499b-5e7e-4827-aba2-be2ebeac4ddc -->","topic":{"id":"bfdbbcbf-5a56-51b8-b0aa-78a059b4cfec","topicId":"73ccd3ba-b5a5-4a3c-98b2-d838dd8a3c58","topicName":"Urticaria","slug":"urticaria","lastRevised":"Last revised in March 2020","chapters":[{"id":"7068e840-7bdb-5596-a56f-1c930bd4b8c4","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"d6e4cfbd-5e36-5755-a780-8091e4b5f146","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"9dde1c08-758f-55bb-b187-0203ded94048","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"3daa7b54-d234-587b-8a56-1bb5cae1efe4","slug":"changes","fullItemName":"Changes"},{"id":"54c42276-0c06-5c18-825f-3c440cb30dfe","slug":"update","fullItemName":"Update"}]},{"id":"5cff12c3-445b-5613-bf5d-dc48effe6502","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"9abed54c-a9ed-58d4-bfce-3f0dddd49698","slug":"goals","fullItemName":"Goals"},{"id":"c2f713b4-e2ec-5e5e-be8f-5c4285be0b6e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"e829abf6-8412-500f-9425-647958addf97","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"92b040fe-6318-560a-9ae0-6f98a6aa9c09","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"2d2f38df-88c4-5895-915d-199eefc9b02a","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"d51180cd-461f-58ad-8f03-20d63965abfb","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"a7fce165-b445-5aa6-9ec9-6ec8016f4bee","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"a5d17f35-ddfe-5931-bfe4-b7dc039baea0","slug":"definition","fullItemName":"Definition"},{"id":"90888c1e-cd37-5fdf-9d0d-b71e51bf56c3","slug":"causes-trigger-factors","fullItemName":"Causes/trigger factors"},{"id":"76d2cc5e-4a3e-5032-8eed-d4010ace1ae7","slug":"prevalence","fullItemName":"Prevalence"},{"id":"507a6931-af71-54ae-a8e7-2b4393c2a41b","slug":"complications","fullItemName":"Complications"},{"id":"091f4740-5801-5ac0-83bd-a7ebbc2a2848","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"fc3a9cf3-3dd4-5456-94e1-90c38c83a0b1","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"513fb45b-36c0-59b5-8f88-13b10509caee","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"e2100cac-0eb7-55e6-b138-9cbc110f1b71","slug":"investigations","fullItemName":"Investigations"},{"id":"2da7bf77-7798-5632-97d4-64d5463f8cde","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"1a1cabda-9d82-5131-8852-db2d844e0b46","fullItemName":"Management","slug":"management","subChapters":[{"id":"f797a7bd-9ca9-523b-8f1e-e2afc927c4ab","slug":"managing-urticaria","fullItemName":"Scenario: Managing urticaria"}]},{"id":"3c7854e6-2fe5-5632-9b63-69f2773b7dd1","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"71f6ce5f-ac94-5ef4-9a02-0aa362883a44","slug":"non-sedating-antihistamines","fullItemName":"Non-sedating antihistamines"},{"id":"8888f0f6-7dd8-55fb-afc0-9e5df55b825a","slug":"sedating-antihistamines","fullItemName":"Sedating antihistamines"},{"id":"b8336773-e3de-5ec0-a85b-93fd72ff7869","slug":"oral-corticosteroids","fullItemName":"Oral corticosteroids"}]},{"id":"c88fe5a9-a559-5661-9a1f-e0ee93078a4d","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"e9950b4f-8af1-5d4b-b531-431ac4a731bb","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"729aa2a2-070b-51ed-9ecf-c29549914b66","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a30a2a17-7629-5022-a313-848d8264fb35","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"f6d1c75a-6a3d-5326-97ca-baff36370740","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"dd5a897e-e7d5-5c98-88b6-35014f9a5dde","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6d27a969-ded2-5d9d-9321-f65e47426edf","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"0d45859d-1b50-538f-84fa-568f43b5c283","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"fc3a9cf3-3dd4-5456-94e1-90c38c83a0b1","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"3dbf5f47-21f6-570b-a193-2766ae7cd648","slug":"basis-for-recommendation-cf3","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field dc4c73ca-3366-403f-b45c-909bb37e7fb4 --><h3>Basis for recommendation</h3><!-- end field dc4c73ca-3366-403f-b45c-909bb37e7fb4 -->","summary":null,"htmlStringContent":"<!-- begin item cf3b3a66-7b7d-4755-b31e-d9463c5a5041 --><!-- begin field e0ee3e4b-6337-4369-a3a6-a7a600d3419d --><p>These recommendations are based on <em>The RCPCH care pathway for children with urticaria, angio-oedema or mastocytosis: an evidence and consensus based national approach </em>published by the Royal College of Paediatrics and Child Health (RCPCH) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Leech, 2011</a>] <em>The diagnosis and management of acute and chronic urticaria: 2014 update </em>published on behalf of the American Academy of Allergy, Asthma, and Immunology (AAAAI), the American College of Allergy, Asthma, and Immunology (ACAAI), and the Joint Council of Allergy, Asthma, and Immunology [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Bernstein, 2014</a>]; <em>The EAACI/GA<sup>2</sup>LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update </em>published by the European Academy of Allergy and Clinical Immunology (EAACI), the Global Allergy and Asthma European Network (GA<sup>2</sup>LEN), the European Dermatology Forum (EDF), and the World Allergy Organization (WAO) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Zuberbier, 2014</a>]; <em>BSACI guideline for the management of chronic urticaria and angioedema </em>published by the British Society for Allergy and Clinical Immunology (BSACI) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Powell, 2015</a>]; <em>The EAACI/GA<sup>2</sup>LEN/EDF/UNEV consensus guideline </em>published by the EAACI, the GA<sup>2</sup>LEN, the EDF, and the urticaria network e.V (UNEV) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Magerl, 2016</a>]; and on expert opinion in review articles on urticaria [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Marzano, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">BMJ, 2016</a>].</p><h4>History and examination</h4><ul><li>Experts advise that the diagnosis of urticaria should be based on a thorough clinical history and examination [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Bernstein, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Zuberbier, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Jafilan, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Marzano, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Powell, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">BMJ, 2016</a>].</li><li>The recommendation to consider assessing the severity of symptoms using a validated tool, such as the Urticaria Activity Score (UAS7), is based on clinical consensus in the EAACI/GA<sup>2</sup>LEN/EDF/WAO guideline, which highlights that because the signs and symptoms are evaluated by the person with urticaria, the UAS7 is a valuable assessment tool [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Zuberbier, 2014</a>].<ul><li>The BSACI guideline does not specifically recommend the use of the UAS7 tool, but states that disease-specific quality of life questionnaires/symptom scores are available for determining the frequency, duration, and severity of urticarial episodes [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Powell, 2015</a>].</li><li>Expert opinion in a review article is that the UAS7 tool 'allows for efficient clinical practice, maximizing the information gathered during patient visits while minimizing the use of resources and time' [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Moolani, 2016</a>].<ul><li>The Urticaria Severity Score (USS), a 12-question tool, is an alternative tool for monitoring disease severity [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Moolani, 2016</a>].</li></ul></li></ul></li><li>The information on immunoglobuling E (IgE)-mediated food allergy is based on expert opinion in the BSACI guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Powell, 2015</a>].</li><li>The characteristics of an urticarial rash are taken from the EAACI/GA<sup>2</sup>LEN/EDF/WAO guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Zuberbier, 2014</a>],the RCPCH guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Leech, 2011</a>], and the AAAAI/ACAAI guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Bernstein, 2014</a>].</li><li>The clinical features of vasculitic urticaria are taken from the EAACI/GA<sup>2</sup>LEN/EDF/WAO guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Zuberbier, 2014</a>], the RCPCH guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Leech, 2011</a>], the AAAAI/ACAAI guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Bernstein, 2014</a>], and a review article on urticaria and angio-oedema [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">BMJ, 2016</a>].</li></ul><h4>Investigations not usually required</h4><ul><li>Expert opinion in guidelines and review articles is that investigations are not always necessary for the diagnosis of urticaria, but may be needed (especially in people with chronic urticaria) to identify treatable associated conditions/trigger factors and to exclude other unusual conditions, such as urticarial vasculitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Zuberbier, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Powell, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Marzano, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">BMJ, 2016</a>].</li><li>See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/urticaria/diagnosis/investigations/\">Investigations</a> for more information.</li></ul><!-- end field e0ee3e4b-6337-4369-a3a6-a7a600d3419d --><!-- end item cf3b3a66-7b7d-4755-b31e-d9463c5a5041 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}